×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
媒體:
210
建立:
2020/06/08
管理者:
系統管理者, TUA秘書處, TUA會計採購組, TUA人資客服組, TUA學術會議組, TUA學術資訊組
搜尋這個資料夾
媒體
(210)
討論區
(0)
常見 Q&A
(0)
知識庫
...
2020年會
摘要
媒體
摘要
摘要
管理者:系統管理者, TUA秘書處, TUA會計採購組, TUA人資客服組, TUA學術會議組, TUA學術資訊組
1.
Non-Discussion Poster
1.1
NDP02: Preliminary experience on combination of androgen deprivation therapy and abiraterone acetate plus prednisolone in patients with de novel metastatic castration sensitive prostate cancer
1.2
NDP03: The prediction of a positive surgical margin after robotic-assisted radical prostatectomy
1.3
NDP04: Biochemical recurrence prediction to prostate cancer with seminal vesicles invasion after robotic-assisted radical prostatectomy
1.4
NDP05: Prostate sarcomatoid carcinoma with chondro-osseous differentiation: A case report
1.5
NDP06: Successive xanthogranulomatous prostatitis after cure of metastatic prostate adenocarcinoma: An extremely rare case report with review of literatures
1.6
NDP07: Non-hodgkin lymphoma of prostate presented with voiding hesitancy and PSA elevation: One case report
1.7
NDP08: A rare case of sudden onset of severe hypertension with hypokalemia due to using abiraterone acetate for a while in patient with castration-resistant prostate cancer
1.8
NDP09: The protoapigenone analogue WYC0209 targeted CD133 as a potent adjuvant agent for anti-cancer stemness in urothelial cancer cells
1.9
NDP10: Hyperthermia enhances the sensitivity to cis-platinum in bladder cancer cells
1.10
NDP12: Comparing cancer behaviors of upper tract urothelial carcinoma in patients having end-stage renal disease with or without kidney transplant and those without end-stage renal disease
1.11
NDP13: Outcome analysis of treating primary adenocarcinoma of urinary bladder: The experience of a single institute
1.12
NDP14: Neoadjuvant chemotherapy combined with immunotherapy followed by radical cystectomy-preliminary results in CMUH
1.13
NDP15: The comparing outcomes in patients with or without a history of benign prostatic hyperplasia surgery before robotic assisted radical prostatectomy: Experience in a single center
1.14
NDP16: En bloc transurethral resection versus conventional resection of bladder cancer
1.15
NDP17: Neoadjuvant chemotherapy and adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma
1.16
NDP18: Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis
1.17
NDP19: Disease control with bacillus calmette-guérin retrograde instillation via ureteral catheter for the recurrent upper tract urothelial carcinoma—a case report
1.18
NDP20: Case report – squamous cell carcinoma of kidney
1.19
NDP22: Malignant triton tumor of pelvis in a male with neurofibromatosis type 1: A case report
1.20
NDP23: Primary renal carcinoid: A case report and literature review
1.21
NDP24: Multiple myeloma with initial testicular extramedullary plasmacytoma: An unexpected encounter
1.22
NDP25: A rare case report: Well-differentiated paratesticular liposarcoma of the left spermatic cord in a 32-year-old patient
1.23
NDP26: Retroperitoneal extragonadal yolk sac tumor with bone and lung metastasis: A rare case report and literature review
1.24
NDP27: Anastomosing hemangioma of kidney: A case report
1.25
NDP28: Venous malformation mimicking retroperitoneal malignant tumor – a case report
1.26
NDP29: Clear cell adenocarcinoma of the prostate ─ a case report
1.27
NDP30: Case report- acute adrenal insufficiency after unilateral adrenalectomy in metastatic lung adenocarcinoma
1.28
NDP31:Testicular glomus tumor: A case report and review of the literature
1.29
NDP32: Renal nephrogenic adenoma: A rare case and literature review; experience of percutaneous endoscopic resection of benign renal tumor
1.30
NDP33: Case report and literature review of bladder paraganglioma
1.31
NDP34: Case report: A rare case - pecoma of bladder
1.32
NDP35:IgG4 related kidney disease found in a woman with polymyalgia rheumatica: A rare case report and literature review
1.33
NDP36: Bladder melanoma – a case report and review of literatures
1.34
NDP37: Unilateral epididymis metastasis from gastric cancer: A case report
1.35
NDP38: Enlarging para-meatal cyst in a young male
1.36
NDP39: Seminal vesicle schwannoma presenting with nocturia
1.37
NDP40: Cystic nephroma masquerading as renal cancer – a case report and review of literatures
1.38
NDP41: Robot-assisted partial cystectomy and umbilectomy for urachal adenocarcinoma : Case report
1.39
NDP42: Case report-discrimination of oncocytoma and renal cell carcinoma
1.40
NDP43: Carcinoembryonic antigen elevation as a presentation of metastatic renal cell carcinoma — a case report
1.41
NDP44: Right robotic-assisted nephrectomy with IVC thrombectomy: A rare case and experience with literature review
1.42
NDP45: A rare case of Xp11.2 translocation renal cell carcinomas with transcription factor E3 (TFE3) gene fusion and literature review in young adults
1.43
NDP46: A rare huge perineal cyst leads elevated prostate specific antigen level and severe lower urinary tract symptoms: A case report and and literature review
1.44
NDP47: Relationship between metabolic syndrome and lower urinary tract symptoms
1.45
NDP48: Zinner syndrome: A rare condition of seminal vesical mass causing lower urinary tract symptoms
1.46
NDP49: Retrograde intrarenal surgery in calyceal diverticular stone: A case report and literature review
1.47
NDP50: Lethal urosepsis – an uncommon complication in treating patient with encrusted ureteral double j stent
1.48
NDP51: Per-pyelotomic nephrolithotomy (PPNL) for "rubbery" staghorn stones of both kidneys – case report and literature review
1.49
NDP52: A case with renal stone and emphysematous pyelonephritis: Treatment with mini-percutaneous nephrolithotomy and negative pressure aspiration sheath
1.50
NDP53: Migration of embolized coil into the renal pelvis with large renal stone formation: A rare case presentation
1.51
NDP54: Migration of permanent radioactive seed implants into bladder with bladder stone formation: Case report and literature review
1.52
NDP55: Pediatric urolithiasis surgical treatment and experience sharing-single medical center cases experiences
1.53
NDP56: Effect of early return to work after laparoscopic total extraperitoneal inguinal hernia repair
1.54
NDP57: Retroperitoneal leiomyosarcoma growing from gerota's fascia: Laparoscopic renal-sparing surgery surgical outcome and follow-up
1.55
NDP59: Surgical drain related bowel obstruction after robotic-assisted laparoscopic radical prostatectomy
1.56
NDP60: Clinical outcomes of peritoneal dialysis in elder ESRD patients
1.57
NDP61: Dual docking robotic surgical technique for hereditary paraganglioma-pheochromocytoma syndrome of synchronous tumors in bladder and adrenal gland
1.58
NDP62: Superior mesenteric artery injury during a laparoscopic left radical nephrectomy: A case report and literature review
1.59
NDP63: Successful removal of retained needle during intracavernosal injection for erectile dysfunction: A case report
1.60
NDP64: Large anesthetic bladder capacity is predictive of better response to hydrodistention in interstitial cystitis/bladder pain syndrome
1.61
NDP65: Case sharing of ureteral endometriosis
1.62
NDP66: Robotic-assisted diverticulectomy of urinary bladder for adult hutch diverticulum with obstructive uropathy: An extremely rare case report and review of literatures
1.63
NDP67: Xanthogranulomatous pyelonephritis presenting as "locally advanced" renalneoplasm : Case report
1.64
NDP68: Testicular ischemia suspected chronic epididymitis related: A case report
1.65
NDP69: Penile fracture with partial urethral disruption during sexual intercourse: A case report
1.66
NDP70: Case report – an unusual penile fracture
1.67
NDP71: Initially diagnosed of lumbar acupuncture related perinephric abscess - a case report
1.68
NDP72: Case report: Severe prostate abscess with prostate-rectum fistula on a poor blood sugar control patient
1.69
NDP73: Special duplication collection system case
1.70
NDP74: Self-inflicted urethrovesical foreign bodies in 13 year old boy: A case report
1.71
NDP75: Hydronephrosis after renal transplantation: Case report
1.72
NDP76: Case sharing of urinothorax
1.73
NDP77: IgG4-related retroperitoneal fibrosis: A rare disease case report and literature review
1.74
NDP78: Successful treatment of bladder perforation after hip joint debridement.
1.75
NDP79: Foreign body in the urinary bladder
1.76
NDP80: Subcorneal pustule over surgical wound after radical cystectomy – a very rare case report
2.
Podium
2.1
PD01-1: The fertility results of intracytoplasmic sperm injection by using testicular sperm in patients with severe oligozoospermia
2.2
PD01-2: The testicular sperm retrieval outcomes in older adolescents with non-mosaic Klinefelter syndrome and azoospermia
2.3
PD01-3: The prevalence of the ejaculatory dysfunction (EjD) with ejaculatory domain of Male Sexual Health Questionnaire (MSHQ-EjD) in the south of Taiwan and two-year ejaculatory volume analysis in NCKUH
2.4
PD01-4: Outcome of intracytoplasmic sperm injection with fresh sperm retrieved by mTESE in klinefelter syndrome patients: Our experience in Taipei Veteran General Hospital
2.5
PD01-5: Preliminary experience of erectile dysfunction treatment using penile platelet rich plasma injection.
2.6
PD01-6: The effect of cavernous nerve stimulation on concurrent intracavernous, intravesical and intrarectal pressures in the rat
2.7
PD02-1: The outcome and survival of radical prostatectomy for localized prostate cancer with positive lymph node
2.8
PD02-2: A multicentre evaluation of the role of the prostate health index (PHI) in regions with differing prevalence of prostate cancer:PHI ≧ 30/35 seems to be the suitable standard to suggest prostate biopsy in Taiwanese with tPSA 4-10 ng/ml
2.9
PD02-3: PSA kinetics parameter in prediction of progression of mCRPC
2.10
PD02-4: MRI-TRUS fusion-targeted prostate biopsy alone compared with systematic biopsy in detecting significant prostate cancer
2.11
PD02-5: Vesicourethral anastomosis leakage after robotic assisted laparoscopic prostatectomy
2.12
PD02-6: The performance of MR/US fusion-targeted prostate biopsy in patients with previous negative biopsies–experience in a single institute
2.13
PD03-1: Contemporary, single-institution nomogram predicting progression in non-muscle invasive bladder urothelial carcinoma patients
2.14
PD03-2: Contemporary, single-institution nomogram predicting progression in non-muscle invasive bladder urothelial carcinoma patients
2.15
PD03-3: Validation of the Age-adjusted Charlson comorbidity index to stratify the mortality risk of Fournier’s gangrene with Taiwan national health insurance research database
2.16
PD03-4: Antibacterial photodynamic therapy mediated by methylene blue for Escherichia coli: An alternative treatment choice for drug-resistant urinary tract infection
2.17
PD03-5: The efficacy of pentosan polysulfate sodium therapy for preventing urinary tract infections in rats
2.18
PD03-6: Evaluating the risk factors for recurrent uncomplicated urinary tract infections in women
2.19
PD04-1: The influence of tumor necrosis factor inhibitor on calcium oxalate crystal formation and adhesion protein expression of hyperoxaluria rat kidney
2.20
PD04-2: A comparative study of simultaneous supine percutaneous nephrolithotomy with ureteroscopic lithotripsy and semi-rigid ureteroscopic lithotripsy in the management of large proximal ureteral calculi
2.21
PD04-3: Poor diabetes control impair the function of tamm-horsfall protein on crystal aggregation inhibition
2.22
PD04-4: Ureterorenoscopic lithotripsy and balloon dilation cause acute kidney injury and distal renal tubule damage
2.23
PD04-5: Meta-analysis of postoperative sepsis and systemic inflammatory response syndrome of positive stone bacterial culture for tubeless mini-percutaneous nephrolithotomy
2.24
PD04-6: Restricted dietary sodium intake in hyperoxaluric rats increases the risk of calcium oxalate nephrolithiasis
2.25
PD05-1: Factor evaluation of chemotherapy-naïve Enzalutamide on castration- resistant prostate cancer patients—Taiwanese cohort
2.26
PD05-2: Tumor Volume, time to PSA nadir and PSA decline rate influence outcomes in metastatic prostate cancer receiving androgen deprivation therapy
2.27
PD05-3: Pathological node-positive renal cell carcinoma is associated with worse survival outcome: A recall for TMN staging revision
2.28
PD05-4: Active contour model of machine learning to evlauate the kidney cancer
2.29
PD05-5: The effect of Metastasectomy on overall survival in metastatic renal cell carcinoma: systemic review and meta-analysis
2.30
PD05-6: Combined immune checkpoint inhibitors in the frontline treatment of metastatic renal cell carcinoma—a real-world experience
2.31
PD06-1: Prader-Willi Syndrome patients and low urinary tract dysfunction
2.32
PD06-2: The urothelial cytoskeleton and cell proliferation protein expression in intersitial cystitis/bladder pain syndrome patients of different phenotype
2.33
PD06-3: Will detrusor acontractile recover after medical or surgical treatment?A longitudinal long tern urodynamic follow-up
2.34
PD06-4: Videourodynamics analysis of the lower urinary tract dysfunctions in patients with chronic brain disorders
2.35
PD06-5: Urothelial cell proliferation, cytoskeleton and barrier function protein expression in the female patients with different phenotypes of urinary tract infection
2.36
PD06-6: Age- and gender-specific nomograms of post-void residual urine in healthy children and adolescents
2.37
PD07-1: High Transaldolase 1 (TALDO1) expression predicts poor survival of upper tract urothelial carcinoma patients
2.38
PD07-2: Kidney sparing surgery preserves renal function without compromising oncological outcome: An inverse probability of treatment weighting analysis in upper tract urothelial carcinoma
2.39
PD07-4: Cis-platinum induces immunity evasion through PD-L1 upregulation in bladder cancer cells
2.40
PD07-5: Influence of body mass index on the prognosis of patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
2.41
PD07-6: The mechanism of miR-30a-3p/MMP2 system regulates cell invasion and tumor growth in baldder cancer
2.42
PD08-1: The prognostic impact of lymph node dissection for upper urinary tract urothelial carcinoma in patient with clinically node-negative disease
2.43
PD08-2: Transfer of prothymosin-α in cancer-derived exosome triggers muscle atrophy in cancer cachexia via TLR4-NF-κB-E3 ubiquitin ligase signaling pathway
2.44
PD08-3: MicroRNA-214 in upper tract urothelial carcinoma and its effect on tumor cell behaviour by targeting CSF-1
2.45
PD08-5: Pheochromocytoma: the “ten-percent” malignant tumor? Ki-67 as an independent factor for recurrence or metastasis
2.46
PD08-6: How is your RNA/DNA quality and sample viability from your resected tumour?
2.47
PD09-1: Management of transplant renal artery stenosis: Two case reports and literature review
2.48
PD09-2: Can donor Tc-99m diethylene triamine pentaacetic acid renal scan predict graft function recovery in living donor kidney transplant?
2.49
PD09-3: Safety and efficacy of intravesical epinephrine instillation for patients with intractable bladder hemorrhage
2.50
PD09-4: The effectiveness of improvement towards inpatients who returned to emergency department within 72 hours after discharge at urology department
2.51
PD09-6: Risk factors for the morbidity of Fournier’s gangrene and the role of early debridement in reducing the mortality and morbidity—a single center experience
2.52
PD10-1: Robotic-assisted adrenalectomy for pheochromocytoma compared to laparoscopic approach
2.53
PD10-2: Different methods in reduction of seroma formation in laparoscopic repair of direct type hernia
2.54
PD10-3: Using R.E.N.A.L. nephrometry and PADUA classification to evaluate perioperative outcomes in renal tumor beyond 4cm underwent minimally invasive partial nephrectomy in a single center
2.55
PD10-4: The role and outcomes of adequate pelvic lymph node dissection in robotic-assisted laparoscopic radical prostatectomy via extraperitoneal route for non-low-risk prostate cancer
2.56
PD10-5: Glove port® robot-assisted extraperitoneal single-port radical prostatectomy
2.57
PD10-6: Effect of human chorionic gonadotropin on tolerogenic cendritic cell formation in transplantation animal model
3.
Moderated Poster
3.1
MP01: Factor evaluation of chemotherapy-naïve abiraterone on castration- resistant prostate cancer patients—Taiwanese cohort
3.2
MP02: Prostate Health index helps to predict positive biopsy of significant prostate cancer for PI-RADS 3 lesion underwent MRI-TRUS fusion-targeted prostate biopsy
3.3
MP03: Predictive factors analysis on biochemical recurrence among patients of extraprostatic extension alone after robotic assisted radical prostatectomy
3.4
MP04: The relationship of prostate health index to the tumor volume after radical prostatectomy
3.5
MP05: The optimal iPSA cutoff value to predict prostate cancer with bone metastasis
3.6
MP06: Initial experience of Prostate Health Index (PHI) and %p2PSA on prostate cancer diagnosis value in a regional teaching hospital
3.7
MP07: Body composition factors measured on MRI correlates with tumor aggressiveness of prostate cancer
3.8
MP08: Marine actinomycete secondary metabolite Lu01-M inhibited prostate cancer cells proliferation by reducing mitochondrial membrane potential
3.9
MP09: Prognosis comparison between adjuvant or salvage therapy vs observation in men with positive surgical margin after robotic-assisted radical prostatectomy
3.10
MP10: Fracture risk of androgen deprivation therapy among non-metastatic prostate cancer population: a systematic review and meta-analysis
3.11
MP11: Retrospective analysis of anastomotic urethroplasty for pelvic fracture urethral distraction defect- 12 years’ experience
3.12
MP12: Urinary tract infection as a detrimental factor for poor outcome of older adults with severe head injury
3.13
MP13: Acute vasitis: A rare case misdiagnosed as lymphadenopathy
3.14
MP14: Discussion on prognostic factors of fournier's gangrene in recent 10 years
3.15
MP15: Laser Flow Cytometry UF-1000i is useful in predicting therapeutic outcomes in women with uncomplicated urinary tract infections
3.16
MP16: Comparison of the efficacy of new laser flow cytometry UF-5000 with UF-1000i in predicting bacteria growth patterns in patients with uncomplicated urinary tract infections
3.17
MP17: Analyze influential factors of patients with prostate abscess underwent conservative or intervention treatment and prognosis of either treatment
3.18
MP19: Robotic assisted vasovasostomy - experience and case analysis from single surgeon
3.19
MP20: Effects of ketogenic diet on the reproductive function in high fat and high cholesterol diet-induced male mice
3.20
MP22: Steroid switch with abiraterone acetate in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A single-center experience
3.21
MP23: Androgen receptor targeted agents and subsequent risk of cardiovascular diseases in patients with metastatic castration-resistant prostate cancer
3.22
MP24: External validation of western prostate cancer risk calculator apps in a taiwanese tertiary medical center
3.23
MP25: Real world experience of steroid switch in patients under Abiraterone therapy: A case series
3.24
MP26: Undetectable nadir PSA is a strong predictor for biochemical failure in patients with positive surgical margin after robotics assisted radical prostatectomy
3.25
MP27: Salvage treatment with high intensity focused ultrasound, cryotherapy, radical prostatectomy or radiotherapy after primary treatment of prostate cancer
3.26
MP28: The study of mechanisms of exosome-transmitted like oncogene long non-coding RNA promotes epithelial-mesenchymal transition in bladder cancer cells
3.27
MP29: Studies on the molecular mechanisms of a novel long intergenic non-protein coding RNA 02470-induced epithelial-mesenchymal transition in human bladder cancer cell lines
3.28
MP30: The study of growth inhibition and MDR modulation of bladder cancer by ellagic acid combination with chemotherapeutics
3.29
MP31: Robotic-assisted surgery for upper urinary tract urolithiasis: An experience including 11 cases
3.30
MP32: Percutaneous nephrolithotomy for Staghorn Renal Stone Single vs. Multiple mini tracts-single institute experiences
3.31
MP33: Distal ureter urolithiasis after ileal conduit-case series and single center experience
3.32
MP34: Incidence and analysis of fever episode after retrograde intrarenal surgery—CMUH experience
3.33
MP35: Combined flexible and rigid nephroscope for supine percutaneous nephrolithotomy- preliminary report
3.34
MP36: Evaluation of the impact of shock wave lithotripsy on kidneys using neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and 3-nitrotyrosine
3.35
MP37: Misplacement of nephrostomy catheter into inferior vena cava: A case report and literature review
3.36
MP38: Complication of percutaneous nephrolithotomy case sharing
3.37
MP39: MAEL promoter hypermethylation and low expression in human testes are associated with spermatogenic failure
3.38
MP40: Anatomic mapping of the internal spermatic vein via subinguinal varicocelectomy with intraoperative vascular Doppler ultrasound
3.39
MP41: A rare complication after TURP: Incarcerated inguinal hernia with bladder diverticulum herniation
3.40
MP42: Comparing the efficacy of onabotulinumtoxinA, sacral neuromodulation, and peripheral tibial nerve stimulation as third line treatment for the management of overactive bladder symptoms in adults: systematic review and network meta-analysis
3.41
MP43: The low-intensity extracorporeal shockwave therapy in the treatment of chronic pelvic pain syndrome: 1-year follow-up
3.42
MP44: Transvaginal ultrasound shear wave elastography to evaluate detrusor wall of acontractile bladder (AcB)/detrusor underactivity (DU) in women: A preliminary report
3.43
MP45: Therapeutic efficacy of platelet-rich plasma in treatment of stress urinary incontinence due to intrinsic sphincter deficiency- which patients may benefit?
3.44
MP46: Correlation of IC/BPS phenotype based on glomerulations and MBC subgroups and clinical characteristics.
3.45
MP47: Therapeutic effects of botulinum toxin a urethral sphincter injection on voiding dysfunction due to different bladder and urethral sphincter dysfunction
3.46
MP48: Treatment outcome of patients with CNS disorders and voiding dysfunction after bladder outlet surgery (TUIP.TURP.TUIBN)
3.47
MP49: Predictive factors for a successful treatment outcome of intravesical botulinum toxin a injection for patients with interstitial cystitis/ bladder pain syndrome
3.48
MP50: The redo surgery of failed hypospadias reconstruction-Sharing the experience of CCH in recent 30 years
3.49
MP51: Multifocal tumors synchronous with elevated systemic inflammation-response index (SIRI) as an indepenfent factor for predicting worse outcomes in upper tract urothelial carcinoma after radical nephroureterectomy
3.50
MP52: Changes in renal function after nephroureterectomy with bladder cuff excision for upper tract urothelial carcinoma
3.51
MP53: The comparison of oncological outcomes between open versus laparoscopic/robotic nephroureterectomy in locally advanced upper urinary tract urothelial carcinoma
3.52
MP54: The contribution of caspase-8 genotypes in the urinary bladder cancer risk in mid-Taiwan
3.53
MP55: Miconazole, an anti-fungal agent, induced autophagic flux serve as a protective mechanism for the survival of bladder cancer cells
3.54
MP56: The prognostic factor of PDL-1 in upper tract urothelial carcinoma
3.55
MP57: The prognostic significance of metallothionein 2A overexpression in patients with urothelial carcinoma
3.56
MP58: Peptide-guided JCPyV virus like particles specifically target bladder cancer cells
3.57
MP59: The combinative effect of Navitoclax and Vesimune for bladder cancer in an orthotopic bladder cancer murine model
3.58
MP60: Comparison of trimodal therapy versus radical cystectomy for each stage of muscle-invasive bladder cancer
3.59
MP61: Conventional laparoscopic surgery versus laparoendoscopic single-site surgery (LESS) for totally extra-peritoneal inguinal hernia repair, including contralateral prophylactic repair
3.60
MP63: Does the timing performing Robot-assisted laparoscopic Radical Prostatectomy (RARP) after prostate biopsy differ the outcomes?
3.61
MP64: Positive surgical margin of locally advanced prostate cancer: Learning curve and literature review
3.62
MP65: Comparison of perioperative and oncological outcomes of robot-assisted versus pure laparoscopic nephroureterectomy in the treatment of upper urinary tract urothelial carcinoma
3.63
MP66: Laparoscopic en mass versus elective internal spermatic vein ligation technique for varicocele
3.64
MP67: Influence of low intensity shockwave therapy on patients with erectile dysfunction initiating phosphodiesterase type 5 inhibitor therapy
3.65
MP68: Nucleic acid tests for BK polyomavirus is Critical in renal transplant recipients
3.66
MP69: Optimize surveillance of post-kidney transplantation cancer in national healthcare system: age-dependent and tumor-dependent
3.67
MP70: Comparison of transperitoneal and retroperitoneal laparoendoscopic single site donor nephrectomy
3.68
MP71: Anti-cancer action of hyperthermia in combination with doxorubicin on activating mitochondrial apoptosis
3.69
MP72: Ectopic adrenocortical tissue in female inguinal hernia sac: A case report
3.70
MP73: Familiar adrenal aldosterone-producing adenoma
3.71
MP74: Nivolumab in metastatic renal cell carcinoma preliminary report
3.72
MP75: Two cases of fumarate hydratase-deficient renal cell carcinoma
3.73
MP76: Develop a computer-assisted, evidences-based, oatient-oriented consensus explanation system for hight risk, low sensitive procedure: Transrectal prostate biopsy
3.74
MP77: Benign renal hemorrhagic cyst mimicking renal neoplasm
3.75
MP78: Juniperus communis extract ameliorates lipopolysaccharide-induced acute kidney injury
3.76
MP79: Mid-term and long-term complications of percutaneous nephrostomy
3.77
MP80: Comparison of levofloxacin and levofloxacin plus gentamicin for prophylaxis of transrectal prostate biopsy